To Develop a Batch of Cost-effective Projects

TJAB creatively sets up a full-chain innovative drug development model with “TjAb Makerspace + incubator + research result transformation accelerator + commercialization”。TjAb Makerspace serves as a start point to provide a lower entrance barrier to attract an innovative team with good projects. TJAB will serves as the incubator and accelerator to systematically provide full incubation services for the good projects, the promising innovative teams and the middle and small size R&D companies in order to help them to grow successfully, to transfer and commercialize their projects in the Tianjin Binhai New Area finally.

Until the end of 2015, TJAB has introduced 320 projects, and cultivated 177 tech-based SMEs.

Tianjin CanSino Biotechnology Inc. (CanSino) has successfully raised 120 million RMB for strategic investment to support its developments of 10 investigative vaccines, including a completed state-of-the-art R&D and pilot production platform.

Acelbio Inc. made a great breakthrough on large-scale plant- cell-culture engineering with 1000L bioreactors, reaching the top-level worldwide.

Tianjin Weikai Bioeng Ltd. (Weikai), chaired by Professor Zhanfeng Cui, fellow of Royal Academy of Engineering, UK, has established “3D perfused cell culture system” and in vitro toxicology technology platform for stem cells